Hostname: page-component-754f97d4cd-89jg8 Total loading time: 0 Render date: 2026-07-22T01:36:12.106Z Has data issue: false hasContentIssue false
  • English
  • Français

Blunted Response of Growth Hormone to Clonidine and Apomorphine in Endogenous Depression

Published online by Cambridge University Press:  02 January 2018

M. Ansseau ,
R. Von Frenckell ,
J. L. Cerfontaine ,
P. Papart ,
G. Franck ,
M. Timsit-Berthier ,
V. Geenen  and
J. J. Legros
M. Ansseau*
Affiliation:
Biological Psychiatry and Psychopharmacology Unit
R. Von Frenckell
Affiliation:
Biological Psychiatry and Psychopharmacology Unit
J. L. Cerfontaine
Affiliation:
Biological Psychiatry and Psychopharmacology Unit
P. Papart
Affiliation:
Biological Psychiatry and Psychopharmacology Unit
G. Franck
Affiliation:
Department of Clinical Neurophysiology and Psychopathology
M. Timsit-Berthier
Affiliation:
Department of Clinical Neurophysiology and Psychopathology
V. Geenen
Affiliation:
Psychoneuroendocrinology Unit
J. J. Legros
Affiliation:
Psychoneuroendocrinology Unit
*
∗ Centre Hospitalier Universitaire (B 35), B-4000 Liège Sart Tilman, Belgium
Get access Rights & Permissions [Opens in a new window]

Abstract

We measured the growth hormone (GH) response to clonidine (an alpha-2-adrenergic agonist) and to apomorphine (a dopaminergic agonist) in 15 major endogenous and 15 minor depressive in-patients matched for gender and age. Results showed a significantly smaller GH response in the major depressives to both Clonidine (P<0.01) and apomorphine (P<0.001). No significant difference existed between the two groups with regard to changes in blood pressure and pulse rate during either test. While major depressives showed a trend toward smaller sedative side-effects than minor depressives after Clonidine, they showed significantly smaller sedative and gastro-intestinal side-effects after apomorphine. No significant correlation was present either in the major depressive or in the minor depressive group between the GH responses following Clonidine and apomorphine challenges. These results support the hypothesis of both noradrenergic and dopaminergic neurotransmitter disturbances in major depression, with individual variability with regard to those biochemical anomalies.

Information

Type
Research Article
Information
The British Journal of Psychiatry , Volume 153 , Issue 1 , July 1988 , pp. 65 - 71
Copyright
Copyright © Royal College of Psychiatrists, 1988 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ansseau, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J. J. & Franck, G. (1984) Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot study. Psychiatry Research, 12, 261–272.Google Scholar
Berrettini, W. H., Nurnberger, J. I. Jr & Simmons-Alling, S. (1987) Growth hormone releasing factor in human cerebrospinal fluid. Psychiatry Research, 22, 141–147.Google Scholar
Boyer, P., Davila, M., Schaub, C. & Nassiet, J. (1986) Growth hormone response to clonidine stimulation in depressive states – Part I. Psychiatrie et Psychobiologie, 1, 189–195.Google Scholar
Casper, R. & Davis, J. (1977) Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology, 2, 105–113.CrossRefGoogle ScholarPubMed
Charney, D. S., Heninger, G. R., Sternberg, D. E., Hafstad, K. M., Giddings, S. & Landis, D. H. (1982) Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy subjects. Archives of General Psychiatry, 39, 290–294.CrossRefGoogle ScholarPubMed
Checkley, S. A. (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychological Medicine, 10, 35–53.Google Scholar
Checkley, S. A., Slade, A. P. & Shur, E. (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. British Journal of Psychiatry, 138, 51–55.Google Scholar
Checkley, S. A., Glass, I. B., Thompson, C., Corn, T. & Robinson, P. (1984) The GH response to clonidine in endogenous as compared with reactive depression. Psychological Medicine, 14, 773–777.CrossRefGoogle ScholarPubMed
Corn, T. H., Hale, A. S., Thompson, C., Bridges, P. K. & Checkley, S. A. (1984a) A comparison of the growth hormone responses to clonidine and apomorphine in the same patients with endogenous depression. British Journal of Psychiatry, 144, 636–639.Google Scholar
Corn, T. H., Thompson, C. & Checkley, S. A. (1984b) Effects of desipramine treatment upon central adrenoreceptor function in normal subjects. British Journal of Psychiatry, 145, 139–145.CrossRefGoogle ScholarPubMed
Costain, D. W., Cowen, P. J., Gelder, M. G. & Grahame-Smith, D. G. (1982) Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. The Lancet, ii, 400–404.CrossRefGoogle Scholar
Dolan, R. J. & Calloway, S. P. (1986) The human growth hormone response to clonidine: relationship to clinical and neuroendocrine profile in depression. American Journal of Psychiatry, 143, 772–774.Google Scholar
Eriksson, E. (1985) Experimental Psycho-neuro-endocrinology: Brain Alpha2-adrenoreceptor Function and Growth Hormone Release. Göteborg: Medi Press.Google Scholar
Ettigi, P., Lal, S., Martin, J. B. & Friesen, H. G. (1975) Effects of sex, oral contraceptives, and glucose loading on apomorphine-induced growth hormone secretion. Journal of Clinical Endocrinology and Metabolism, 40, 1094–1098.Google Scholar
Franchimont, P. (1968) Le dosage radio-immunologique de l'hormone de croissance humaine. Cahiers Médicaux Lyonnais, 44, 887–898.Google Scholar
Jimerson, D. C., Cutler, N. R., Post, R. M., Rey, A., Gold, P. W., Brown, G. M. & Bunney, W. E. Jr (1984) Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects. Psychiatry Research, 13, 1–12.CrossRefGoogle ScholarPubMed
Krishnan, K. R. R., Manepalli, A., Rayasam, M. L., Melville, G., Daughtry, G., Rivier, J., Vale, W., Thorner, M. D. & Nemeroff, C. B. (1986) Somatotroph response to GHRF in depression. 15th CINP Congress, San Juan, Puerto Rico.Google Scholar
Lal, S., Martin, J. B., de la Vega, C. E. & Friesen, H. G. (1975) Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men. Clinical Endocrinology, 4, 277–285.CrossRefGoogle ScholarPubMed
Lal, S. & Martin, J. B. (1980) Neuroanatomy and neuropharmacological regulation of neuroendocrine function. In Handbook of Biological Psychiatry – Part III. Brain Mechanisms and Abnormal Behavior – Genetics and Neuroendocrinology (eds Van Praag, H. M., Lader, M. H., Rafaelsen, O. J. & Sachar, E. J.). New York: Marcel Dekker.Google Scholar
Linkowski, P., Brauman, H. & Mendlewicz, J. (1983) Prolactin and growth hormone response to levodopa in affective illness. Neuropsychobiology, 9, 108–112.Google Scholar
Maany, I., Mendels, J., Frazer, A. & Brunswick, D. (1979) A study of growth hormone release in depression. Neuropsychobiology, 5, 282–289.Google Scholar
Matussek, N. (1988) Catecholamines and mood: neuroendocrine aspects. In Current Topics in Neuroendocrinology – Vol. 8. Neuroendocrinology and Mood (eds Fuxe, K., Ganten, D. & Pfaff, D.). Berlin: Springer.Google Scholar
Matussek, N., Ackenheil, M., Hippius, H., Müller, F. T., Schröder, F., Schultes, H. & Wasilewski, B. (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Research, 2, 25–36.CrossRefGoogle ScholarPubMed
Meltzer, H. Y., Kolakowska, T., Fang, V. S., Fogg, L., Robertson, A., Lewine, R., Strahilevitz, M. & Busch, D. (1984) Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Archives of General Psychiatry, 41, 512–519.Google Scholar
Mendelwicz, J., Linkowski, P., Kerkhofs, M., Desmedt, D., Goldstein, J., Copinschi, G. & Van Cauter, E. (1985) Diurnal hypersecretion of growth hormone in depression. Journal of Clinical Endocrinology and Metabolism, 60, 505–512.Google Scholar
Pettinger, W. A. (1980) Pharmacology of Clonidine. Journal of Cardiovascular Pharmacology, 2 (Suppl. 1), S21–S28.CrossRefGoogle ScholarPubMed
Risch, S., Janowsky, D., Judd, L., Gillin, J. & Ehlers, C. (1986) Attenuated growth hormone response to human growth hormone releasing factor in depressed subjects vs. matched controls. 15th CINP Congress, San Juan, Puerto Rico.Google Scholar
La Rossa, J. T., Agrin, R. & Melby, J. C. (1977) Apomorphine-stimulated growth hormone release. American Journal of Medicine, 63, 909–913.CrossRefGoogle ScholarPubMed
Rotrosen, J., Angrist, B. M., Gershon, S., Sachar, E. J. & Halpern, F. S. (1976) Dopamine receptor alteration in schizophrenia: neuroendocrine evidence. Psychopharmacology, 51, 1–7.Google Scholar
Rotrosen, J., Angrist, B. M., Gershon, S., Paquin, J., Branchey, L., Oleshansky, M., Halpern, F. & Sachar, E. J. (1979) Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research. British Journal of Psychiatry, 135, 444–456.CrossRefGoogle ScholarPubMed
Sachar, E. J., Altman, N., Gruen, P. H., Glassman, A., Halpern, F. S. & Sassin, J. (1975) Human growth hormone response to levodopa: relation to menopause, depression and plasma dopa concentration. Archives of General Psychiatry, 32, 502–503.Google Scholar
Siever, L. J., Uhde, T. W., Silberman, E. K., Jimerson, D. C., Aloi, J. A., Post, R. M. & Murphy, D. L. (1982) Growth hormone response to Clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Research, 6, 171–183.Google Scholar
Siever, L. J. & Uhde, T. W. (1984) New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha2-adrenergic agonist clonidine. Biological Psychiatry, 19, 131–156.Google Scholar
Siever, L. J., Uhde, T. W., Jimerson, D. C., Lake, C. R., Silberman, E. R., Post, R. M. & Murphy, D. L. (1984) Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. American Journal of Psychiatry, 141, 733–741.Google Scholar
Spyraki, C. & Fibiger, H. C. (1982) Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha2-adrenoreceptors. Journal of Neural Transmission, 54, 153–163.Google Scholar
Willner, P. (1985) Depression: a Psychobiological Synthesis. New York: Wiley.Google Scholar

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.